Amgen stock analysis
Amgen passes 5 of 8 fundamental tests, a score of 6/10. On the daily chart it is in an uptrend, RSI 62, 3% below its 52-week high: uptrend, no fresh entry: wait for a pullback or breakout. Its own volatility puts the likely range at $397.41–$470.67 a month from now and $322.64–$579.75 in a year (68% bands).
Fundamentals 6/10
- Market cap
- $233.8 B
- P/E · forward
- 26.9 · 17.7
- PEG · P/B
- 2.6 · 20.0
- ROE · net margin
- +91% · +23%
- Revenue · earnings growth
- +10% · +65%
- Debt / equity
- 490%
- Dividend · beta
- 2.3% · 0.4
- Next results
- 3 Nov 2026
- ✓ ROE above 15%
- ✓ Net margin above 10%
- ✕ Revenue growing over 10%
- ✓ Earnings growing
- ✕ Debt/equity under 100%
- ✓ Positive free cash flow
- ✓ Forward P/E under trailing (earnings expected up)
- ✕ PEG under 2
Swing technicals (daily)
- Trend
- up · 50d above 200d
- RSI(14)
- 62
- 20 / 50 / 200-day avg
- $413.39 / $415.01 / $368.90
- 20-day breakout
- above $441.76 · below $378.51
- ATR(14)
- $10.66 (2.5% a day)
- 52-week range
- $288.00 – $447.03
- Return 3m · 6m · 1y
- +19% · +22% · +45%
What the price could do
| In | Likely range (68%) |
|---|---|
| 1 mo | $397.41 – $470.67 (-8% / +9%) |
| 3 mo | $373.55 – $500.73 (-14% / +16%) |
| 6 mo | $351.55 – $532.06 (-19% / +23%) |
| 1 year | $322.64 – $579.75 (-25% / +34%) |
Analysts (29): hold, mean target $394.98 (-9%)
From its own volatility (29% a year), no drift assumed: what its swings allow, not a forecast.
Amgen news · last two days
News lean: Neutral- 13h agoAmgen's Q3 2026 Earnings: What to ExpectBarchart
- 17h agoWhen Amgen's Forecast And Chart Say The Same Thing, Pay AttentionTrefis
- 18h agoIs Amgen Stock Increasing Your Market Risk?Trefis
- 45h agoAmgen (AMGN) Exceeds Market Returns: Some Facts to ConsiderZacks
- 2d agoAMGN vs. MRK: Which Pharma Giant’s Dividend Actually Has Room to Grow24/7 Wall St.
- 3d agoAmgen (AMGN) Gains Attention On Aging Treatments, Is The Upside Already Priced In?Simply Wall St.
- 3d agoWhat Could Amgen (AMGN) 70% Remission Trial Result Mean For Its Pipeline?Simply Wall St.
- 4d agoIs Amgen Stock Worth More Than Its Competitors?Trefis
- 4d agoGoldman Sachs Adjusts Price Target on Amgen to $481 From $475MT Newswires
Its order flow and footprint, the AI read of every headline, the expected move, and your own holdings beside it, with your broker connected.
Information and analytics for education only, not investment advice or a recommendation to buy or sell. Alephix Intelligence is not registered with SEBI as an investment adviser or research analyst. Prices may be delayed; figures come from public market data.